Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Robak

Showing results (191-200 of 292) with videos related to

Pageof 30
Sort By:
Leukemia & Lymphoma|April 1, 1996
Fulminant 2-chlorodeoxyadenosine-related peripheral neuropathy in a patient with paraneoplastic neurological syndrome associated with lymphomaK Warzocha, E Krykowksi, J Góra-Tybor, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
2-Chlorodeoxyadenosine inhibits activity of adenosine deaminase and S-adenosylhomocysteine hydrolase in patients with chronic lymphocytic leukaemiaK Warzocha, K Fabianowska-Majewska, J Bloński, et al.
Immunology Letters|April 29, 1998
Cytokines serum levels as the markers of thyroid activation in Graves' diseaseJ Komorowski, J Jankiewicz, T Robak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2015
Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upT Robak, E Matutes, D Catovsky, et al.
Acta Haematologica Polonica|January 1, 1993
[Therapeutic problems during pregnancy and delivery in two women with aplastic anemia]T Robak, T Olszańska-Skorek, E Krykowski, et al.
Mediators of Inflammation|January 1, 1994
A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-alpha and its Muteins on Leukaemia L1210 and Leukaemia P388 in MiceK Warzocha, J Góra-Tybor, M Kwinkowski, et al.
Advances in Experimental Medicine and Biology|January 11, 2002
2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cellsJ Gora-Tybor, E Lech-Miranda, J Z Blonski, et al.
European Cytokine Network|September 22, 2001
Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activityE Robak, A Woźniacka, A Sysa-Jedrzejowska, et al.
Polskie Archiwum Medycyny Wewnetrznej|October 1, 1991
[Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)]M Błasińska-Morawiec, A Płuzańska, E Krykowski, et al.
Neoplasma|August 26, 1998
Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's diseaseP Smolewski, H Niewiadomska, J Z Błonski, et al.
Pageof 30

Showing results (191-200 of 292) with videos related to

Sort By:
Pageof 30
Leukemia & Lymphoma|April 1, 1996
Fulminant 2-chlorodeoxyadenosine-related peripheral neuropathy in a patient with paraneoplastic neurological syndrome associated with lymphomaK Warzocha, E Krykowksi, J Góra-Tybor, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
2-Chlorodeoxyadenosine inhibits activity of adenosine deaminase and S-adenosylhomocysteine hydrolase in patients with chronic lymphocytic leukaemiaK Warzocha, K Fabianowska-Majewska, J Bloński, et al.
Immunology Letters|April 29, 1998
Cytokines serum levels as the markers of thyroid activation in Graves' diseaseJ Komorowski, J Jankiewicz, T Robak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2015
Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upT Robak, E Matutes, D Catovsky, et al.
Acta Haematologica Polonica|January 1, 1993
[Therapeutic problems during pregnancy and delivery in two women with aplastic anemia]T Robak, T Olszańska-Skorek, E Krykowski, et al.
Mediators of Inflammation|January 1, 1994
A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-alpha and its Muteins on Leukaemia L1210 and Leukaemia P388 in MiceK Warzocha, J Góra-Tybor, M Kwinkowski, et al.
Advances in Experimental Medicine and Biology|January 11, 2002
2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cellsJ Gora-Tybor, E Lech-Miranda, J Z Blonski, et al.
European Cytokine Network|September 22, 2001
Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activityE Robak, A Woźniacka, A Sysa-Jedrzejowska, et al.
Polskie Archiwum Medycyny Wewnetrznej|October 1, 1991
[Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)]M Błasińska-Morawiec, A Płuzańska, E Krykowski, et al.
Neoplasma|August 26, 1998
Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's diseaseP Smolewski, H Niewiadomska, J Z Błonski, et al.
Pageof 30